speb/financial-data huggingface dataset:
HMD.AX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2896.00
HMD.AX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 1979409.00
HMD.AX income_statement (annual, 2025-12-31) — Net Income: -4131627.00
HMD.AX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -4131627.00
HMD.AX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -4131627.00
HMD.AX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4131627.00
HMD.AX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4131627.00
HMD.AX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -4131627.00
HMD.AX income_statement (annual, 2025-12-31) — Net Interest Income: -1800.00
HMD.AX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -68917.00
HMD.AX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -68917.00
HMD.AX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1800.00
HMD.AX balance_sheet (annual, 2025-12-31) — Net PPE: 2896.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Net PPE: 2896.00
HMD.AX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 931029.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 931029.00
HMD.AX income_statement (annual, 2025-12-31) — Normalized EBITDA: -2973051.00
HMD.AX income_statement (annual, 2025-12-31) — Normalized Income: -3121116.00
HMD.AX income_statement (annual, 2025-12-31) — Operating Income: -3603134.00
HMD.AX income_statement (annual, 2025-12-31) — Operating Revenue: 293380.00
HMD.AX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1070202742.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1070202742.00
HMD.AX balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 44928.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 44928.00
HMD.AX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 3221233.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 3221233.00
HMD.AX income_statement (annual, 2025-12-31) — Other Gand A: 775591.00
HMD.AX income_statement (annual, 2025-12-31) — Other Income Expense: -526693.00
HMD.AX balance_sheet (annual, 2025-12-31) — Other Investments: 39322.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Other Investments: 39322.00
HMD.AX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 483818.00
HMD.AX income_statement (annual, 2025-12-31) — Other Operating Expenses: 1851434.00
HMD.AX balance_sheet (annual, 2025-12-31) — Other Payable: 165399.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Other Payable: 165399.00
HMD.AX balance_sheet (annual, 2025-12-31) — Other Receivables: 40998.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 40998.00
HMD.AX balance_sheet (annual, 2025-12-31) — Payables: 277575.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Payables: 277575.00
HMD.AX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 277575.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 277575.00
HMD.AX cash_flow (annual, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -3793658.00
HMD.AX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 37098.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 37098.00
HMD.AX income_statement (annual, 2025-12-31) — Pretax Income: -4131627.00
HMD.AX income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 94945.00
HMD.AX cash_flow (annual, 2025-12-31) — Receiptsfrom Government Grants: 138225.00
HMD.AX balance_sheet (annual, 2025-12-31) — Receivables: 40998.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Receivables: 40998.00
HMD.AX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 143856.00
HMD.AX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -68917.00
HMD.AX income_statement (annual, 2025-12-31) — Research And Development: 19148.00
HMD.AX balance_sheet (annual, 2025-12-31) — Retained Earnings: -44183792.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -44183792.00
HMD.AX income_statement (annual, 2025-12-31) — Salaries And Wages: 767895.00
HMD.AX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 243645.00
HMD.AX income_statement (annual, 2025-12-31) — Selling General And Administration: 1787131.00
HMD.AX balance_sheet (annual, 2025-12-31) — Share Issued: 1070202742.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Share Issued: 1070202742.00
HMD.AX income_statement (annual, 2025-12-31) — Special Income Charges: -1010511.00
HMD.AX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 931029.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 931029.00
HMD.AX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 931029.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 931029.00
HMD.AX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
HMD.AX income_statement (annual, 2025-12-31) — Tax Provision: 0.00
HMD.AX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
HMD.AX balance_sheet (annual, 2025-12-31) — Total Assets: 1490990.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Total Assets: 1490990.00
HMD.AX balance_sheet (annual, 2025-12-31) — Total Capitalization: 1168487.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1168487.00
HMD.AX balance_sheet (annual, 2025-12-31) — Total Debt: 282386.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Total Debt: 282386.00
HMD.AX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 931029.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 931029.00
HMD.AX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 559961.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 559961.00
HMD.AX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 42218.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 42218.00
HMD.AX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 237458.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 237458.00
HMD.AX income_statement (annual, 2025-12-31) — Total Unusual Items: -1010511.00
HMD.AX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1010511.00
HMD.AX balance_sheet (annual, 2025-12-31) — Working Capital: 1126269.00
HMD.AX balance_sheet (quarterly, 2025-12-31) — Working Capital: 1126269.00
HME.V cash_flow (annual, 2021-12-31) — Asset Impairment Charge: -1913000.00
HME.V cash_flow (annual, 2021-12-31) — Common Stock Issuance: 375700.00
HME.V balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 0.00
HME.V balance_sheet (annual, 2021-12-31) — Current Deferred Taxes Liabilities: 0.00
HME.V cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 6097000.00
HME.V income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
HME.V balance_sheet (annual, 2021-12-31) — Hedging Assets Current: 433000.00
HME.V income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: -1913000.00
HME.V cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 375700.00
HME.V cash_flow (annual, 2021-12-31) — Issuance Of Debt: 15505000.00
HME.V balance_sheet (annual, 2021-12-31) — Long Term Debt: 15505000.00
HME.V cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 15505000.00
HME.V balance_sheet (annual, 2021-12-31) — Net Debt: 15505000.00
HME.V cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
HME.V balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 0.00
HME.V income_statement (annual, 2021-12-31) — Normalized Income: 15144000.00
HME.V cash_flow (annual, 2021-12-31) — Operating Gains Losses: 6097000.00
HME.V balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 6927000.00
HME.V balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 433370.00
HME.V income_statement (annual, 2021-12-31) — Other Special Charges: 768680.00
HME.V cash_flow (annual, 2021-12-31) — Purchase Of PPE: -10934000.00
HME.V balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 26757000.00
HME.V income_statement (annual, 2021-12-31) — Total Operating Income As Reported: 15059000.00
HME.V income_statement (annual, 2021-12-31) — Total Other Finance Cost: 1162000.00
HME.V income_statement (annual, 2022-12-31) — +Operating Expense: 6732000.00
HME.V income_statement (annual, 2022-12-31) — +Total Revenue: 96699000.00
HME.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 6379000.00
HME.V balance_sheet (annual, 2022-12-31) — Accounts Receivable: 142000.00
HME.V balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -70669000.00
HME.V balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 5330000.00
HME.V cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 842000.00
HME.V income_statement (annual, 2022-12-31) — Basic Average Shares: 99282362.00
HME.V income_statement (annual, 2022-12-31) — Basic EPS: 0.21
HME.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 0.00
HME.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -17124000.00
HME.V cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -17124000.00
HME.V balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3937000.00
HME.V balance_sheet (annual, 2022-12-31) — Capital Stock: 67138000.00
HME.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 152000.00
HME.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 152000.00
HME.V cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -7683000.00
HME.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -26092000.00
HME.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -18847000.00
HME.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 45091000.00
HME.V cash_flow (annual, 2022-12-31) — Change In Working Capital: -911000.00
HME.V cash_flow (annual, 2022-12-31) — Changes In Cash: 152000.00
HME.V balance_sheet (annual, 2022-12-31) — Common Stock: 67138000.00
HME.V cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -7683000.00
HME.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 53000000.00
HME.V cash_flow (annual, 2022-12-31) — Common Stock Payments: -3387000.00
HME.V income_statement (annual, 2022-12-31) — Cost Of Revenue: 46313000.00
HME.V balance_sheet (annual, 2022-12-31) — Current Assets: 5825000.00
HME.V balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 633000.00
HME.V balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 633000.00
HME.V balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 212000.00
HME.V balance_sheet (annual, 2022-12-31) — Current Deferred Taxes Liabilities: 212000.00
HME.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 7839000.00
HME.V balance_sheet (annual, 2022-12-31) — Current Provisions: 198000.00
HME.V cash_flow (annual, 2022-12-31) — Deferred Income Tax: 8131000.00
HME.V cash_flow (annual, 2022-12-31) — Deferred Tax: 8131000.00
HME.V cash_flow (annual, 2022-12-31) — Depletion: 7216000.00
HME.V cash_flow (annual, 2022-12-31) — Depreciation: 668000.00
HME.V cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 7884000.00
HME.V cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 668000.00
HME.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 101197960.00
HME.V income_statement (annual, 2022-12-31) — Diluted EPS: 0.21
HME.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 21317000.00
HME.V balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 18000.00
HME.V income_statement (annual, 2022-12-31) — EBIT: 30589000.00
HME.V income_statement (annual, 2022-12-31) — EBITDA: 38473000.00
HME.V cash_flow (annual, 2022-12-31) — End Cash Position: 152000.00
HME.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: -26092000.00
HME.V cash_flow (annual, 2022-12-31) — Free Cash Flow: 27967000.00
HME.V cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 6783000.00
HME.V income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -12223000.00
HME.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 6689000.00
HME.V balance_sheet (annual, 2022-12-31) — Gross PPE: 142752000.00
HME.V income_statement (annual, 2022-12-31) — Gross Profit: 50386000.00
HME.V balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 0.00
HME.V income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 842000.00
HME.V income_statement (annual, 2022-12-31) — Interest Expense: 929000.00
HME.V income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 929000.00
HME.V income_statement (annual, 2022-12-31) — Interest Income: 0.00
HME.V income_statement (annual, 2022-12-31) — Interest Income Non Operating: 0.00
HME.V cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 700000.00
HME.V balance_sheet (annual, 2022-12-31) — Invested Capital: 53000000.00
HME.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -18847000.00
HME.V balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3304000.00
HME.V balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3304000.00
HME.V cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -689000.00
HME.V balance_sheet (annual, 2022-12-31) — Long Term Provisions: 5750000.00
HME.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -3387000.00
HME.V income_statement (annual, 2022-12-31) — Net Income: 21317000.00
HME.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 21317000.00
HME.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 21317000.00
HME.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 21317000.00
HME.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 21317000.00
HME.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 21317000.00
HME.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 21317000.00
HME.V income_statement (annual, 2022-12-31) — Net Interest Income: -929000.00
HME.V cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -16194000.00
HME.V cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -16194000.00
HME.V income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -929000.00
HME.V cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -1723000.00
HME.V balance_sheet (annual, 2022-12-31) — Net PPE: 72083000.00
HME.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -17124000.00
HME.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 53000000.00
HME.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 8131000.00
HME.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 8131000.00
HME.V income_statement (annual, 2022-12-31) — Normalized EBITDA: 51538000.00
HME.V income_statement (annual, 2022-12-31) — Normalized Income: 30706973.20
HME.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: 45091000.00
HME.V cash_flow (annual, 2022-12-31) — Operating Gains Losses: 6783000.00
HME.V income_statement (annual, 2022-12-31) — Operating Income: 43654000.00
HME.V income_statement (annual, 2022-12-31) — Operating Revenue: 96699000.00
HME.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 101978939.00
HME.V balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 417000.00
HME.V income_statement (annual, 2022-12-31) — Other Gand A: 4071000.00
HME.V income_statement (annual, 2022-12-31) — Other Income Expense: -13065000.00
HME.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: -641000.00
HME.V balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 116000.00
HME.V income_statement (annual, 2022-12-31) — Other Operating Expenses: 43000.00
HME.V balance_sheet (annual, 2022-12-31) — Other Properties: 5397000.00
HME.V balance_sheet (annual, 2022-12-31) — Other Receivables: 4685000.00
HME.V balance_sheet (annual, 2022-12-31) — Payables: 6591000.00
HME.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 6591000.00
HME.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 828000.00
HME.V income_statement (annual, 2022-12-31) — Pretax Income: 29660000.00
HME.V cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1172000.00
HME.V balance_sheet (annual, 2022-12-31) — Properties: 137355000.00
HME.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -17124000.00
HME.V balance_sheet (annual, 2022-12-31) — Receivables: 4845000.00
HME.V income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 46313000.00
HME.V income_statement (annual, 2022-12-31) — Reconciled Depreciation: 7884000.00
HME.V cash_flow (annual, 2022-12-31) — Repayment Of Debt: -689000.00
HME.V cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -3387000.00
HME.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -19468000.00
HME.V income_statement (annual, 2022-12-31) — Salaries And Wages: 2618000.00
HME.V income_statement (annual, 2022-12-31) — Selling General And Administration: 6689000.00
HME.V balance_sheet (annual, 2022-12-31) — Share Issued: 101978939.00
HME.V income_statement (annual, 2022-12-31) — Special Income Charges: -842000.00
HME.V cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2618000.00
HME.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: 53000000.00
HME.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: 53000000.00
HME.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -3675026.80
HME.V income_statement (annual, 2022-12-31) — Tax Provision: 8343000.00
HME.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.28
HME.V balance_sheet (annual, 2022-12-31) — Total Assets: 78024000.00
HME.V balance_sheet (annual, 2022-12-31) — Total Capitalization: 53000000.00
HME.V balance_sheet (annual, 2022-12-31) — Total Debt: 3937000.00
HME.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 53000000.00
HME.V income_statement (annual, 2022-12-31) — Total Expenses: 53045000.00
HME.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 25024000.00
HME.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 72199000.00
HME.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 17185000.00
HME.V income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 37372000.00
HME.V balance_sheet (annual, 2022-12-31) — Total Tax Payable: 212000.00
HME.V income_statement (annual, 2022-12-31) — Total Unusual Items: -13065000.00
HME.V income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -13065000.00
HME.V cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: -932000.00
HME.V balance_sheet (annual, 2022-12-31) — Working Capital: -2014000.00
HME.V income_statement (annual, 2023-12-31) — +Operating Expense: 5791000.00
HME.V income_statement (annual, 2023-12-31) — +Total Revenue: 84472000.00
HME.V balance_sheet (annual, 2023-12-31) — Accounts Payable: 3298000.00
HME.V balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1206000.00
HME.V balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -83866000.00
HME.V balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 6415000.00
HME.V cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 4815000.00
HME.V income_statement (annual, 2023-12-31) — Basic Average Shares: 100928512.00
HME.V income_statement (annual, 2023-12-31) — Basic EPS: 0.24
HME.V cash_flow (annual, 2023-12-31) — Beginning Cash Position: 152000.00
HME.V cash_flow (annual, 2023-12-31) — Capital Expenditure: -14119000.00
HME.V cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -14119000.00
HME.V balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 3404000.00
HME.V balance_sheet (annual, 2023-12-31) — Capital Stock: 63164000.00
HME.V balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 7189000.00
HME.V balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 7189000.00
HME.V cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -13083000.00
HME.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -17748000.00
HME.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -19456000.00
HME.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 44241000.00
HME.V cash_flow (annual, 2023-12-31) — Change In Working Capital: 5266000.00
HME.V cash_flow (annual, 2023-12-31) — Changes In Cash: 7037000.00
HME.V balance_sheet (annual, 2023-12-31) — Common Stock: 63164000.00
HME.V cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -13083000.00
HME.V balance_sheet (annual, 2023-12-31) — Common Stock Equity: 61223000.00
HME.V cash_flow (annual, 2023-12-31) — Common Stock Payments: -4095000.00
HME.V income_statement (annual, 2023-12-31) — Cost Of Revenue: 41645000.00
HME.V balance_sheet (annual, 2023-12-31) — Current Assets: 14318000.00
HME.V balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 702000.00
HME.V balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 702000.00
HME.V balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 7224000.00
HME.V balance_sheet (annual, 2023-12-31) — Current Deferred Taxes Liabilities: 7224000.00
HME.V balance_sheet (annual, 2023-12-31) — Current Liabilities: 11408000.00
HME.V balance_sheet (annual, 2023-12-31) — Current Provisions: 184000.00
HME.V cash_flow (annual, 2023-12-31) — Deferred Income Tax: 842000.00
HME.V cash_flow (annual, 2023-12-31) — Deferred Tax: 842000.00
HME.V cash_flow (annual, 2023-12-31) — Depletion: 8209000.00
HME.V cash_flow (annual, 2023-12-31) — Depreciation: 808000.00
HME.V cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 9017000.00
HME.V cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 808000.00
HME.V income_statement (annual, 2023-12-31) — Diluted Average Shares: 101894197.00
HME.V income_statement (annual, 2023-12-31) — Diluted EPS: 0.24
HME.V income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 24195000.00
HME.V balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 20000.00
HME.V income_statement (annual, 2023-12-31) — EBIT: 33197000.00
HME.V income_statement (annual, 2023-12-31) — EBITDA: 42214000.00
HME.V cash_flow (annual, 2023-12-31) — End Cash Position: 7189000.00
HME.V cash_flow (annual, 2023-12-31) — Financing Cash Flow: -17748000.00
HME.V cash_flow (annual, 2023-12-31) — Free Cash Flow: 30122000.00
HME.V income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
HME.V income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 855000.00
HME.V income_statement (annual, 2023-12-31) — General And Administrative Expense: 5470000.00
HME.V balance_sheet (annual, 2023-12-31) — Gross PPE: 160169000.00
HME.V income_statement (annual, 2023-12-31) — Gross Profit: 42827000.00
HME.V balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 208000.00
HME.V income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 4815000.00
HME.V income_statement (annual, 2023-12-31) — Interest Expense: 731000.00
HME.V income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 731000.00
HME.V income_statement (annual, 2023-12-31) — Interest Income: 121000.00
HME.V income_statement (annual, 2023-12-31) — Interest Income Non Operating: 121000.00
HME.V cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 500000.00
HME.V balance_sheet (annual, 2023-12-31) — Invested Capital: 61223000.00
HME.V cash_flow (annual, 2023-12-31) — Investing Cash Flow: -19456000.00
HME.V balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2702000.00
HME.V balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2702000.00
HME.V cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -636000.00
HME.V balance_sheet (annual, 2023-12-31) — Long Term Provisions: 6432000.00
HME.V cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -4095000.00
HME.V income_statement (annual, 2023-12-31) — Net Income: 24195000.00
HME.V income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 24195000.00
HME.V income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 24195000.00
HME.V income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 24195000.00
HME.V income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 24195000.00
HME.V cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 24195000.00
HME.V income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 24195000.00
HME.V income_statement (annual, 2023-12-31) — Net Interest Income: -610000.00
HME.V cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -636000.00
HME.V cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -636000.00
HME.V income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -610000.00
HME.V cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -5337000.00
HME.V balance_sheet (annual, 2023-12-31) — Net PPE: 76303000.00
HME.V cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
HME.V balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 61223000.00
HME.V balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 8972000.00
HME.V balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 8972000.00
HME.V income_statement (annual, 2023-12-31) — Normalized EBITDA: 46174000.00
HME.V income_statement (annual, 2023-12-31) — Normalized Income: 27146155.05
HME.V cash_flow (annual, 2023-12-31) — Operating Cash Flow: 44241000.00
HME.V income_statement (annual, 2023-12-31) — Operating Income: 37036000.00
HME.V income_statement (annual, 2023-12-31) — Operating Revenue: 84472000.00
HME.V balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 99340339.00
HME.V income_statement (annual, 2023-12-31) — Other Gand A: 4624000.00
HME.V income_statement (annual, 2023-12-31) — Other Income Expense: -3960000.00
HME.V cash_flow (annual, 2023-12-31) — Other Non Cash Items: -115000.00
HME.V balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 116000.00
HME.V income_statement (annual, 2023-12-31) — Other Operating Expenses: 321000.00
HME.V balance_sheet (annual, 2023-12-31) — Other Properties: 5511000.00
HME.V balance_sheet (annual, 2023-12-31) — Other Receivables: 4525000.00
HME.V balance_sheet (annual, 2023-12-31) — Payables: 10522000.00
HME.V balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 10522000.00
HME.V balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1170000.00
HME.V income_statement (annual, 2023-12-31) — Pretax Income: 32466000.00
HME.V cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 66000.00
HME.V balance_sheet (annual, 2023-12-31) — Properties: 154658000.00
HME.V cash_flow (annual, 2023-12-31) — Purchase Of PPE: -14119000.00
HME.V balance_sheet (annual, 2023-12-31) — Receivables: 5751000.00
HME.V income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 41645000.00
HME.V income_statement (annual, 2023-12-31) — Reconciled Depreciation: 9017000.00
HME.V cash_flow (annual, 2023-12-31) — Repayment Of Debt: -636000.00
HME.V cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -4095000.00
HME.V balance_sheet (annual, 2023-12-31) — Retained Earnings: -8356000.00
HME.V income_statement (annual, 2023-12-31) — Salaries And Wages: 846000.00
HME.V cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
HME.V income_statement (annual, 2023-12-31) — Selling General And Administration: 5470000.00
HME.V balance_sheet (annual, 2023-12-31) — Share Issued: 99340339.00
HME.V income_statement (annual, 2023-12-31) — Special Income Charges: -4815000.00
HME.V cash_flow (annual, 2023-12-31) — Stock Based Compensation: 846000.00
HME.V balance_sheet (annual, 2023-12-31) — Stockholders Equity: 61223000.00
HME.V balance_sheet (annual, 2023-12-31) — Tangible Book Value: 61223000.00
HME.V income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1008844.95
HME.V income_statement (annual, 2023-12-31) — Tax Provision: 8271000.00
HME.V income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
HME.V balance_sheet (annual, 2023-12-31) — Total Assets: 90737000.00
HME.V balance_sheet (annual, 2023-12-31) — Total Capitalization: 61223000.00
HME.V balance_sheet (annual, 2023-12-31) — Total Debt: 3404000.00
HME.V balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 61223000.00
HME.V income_statement (annual, 2023-12-31) — Total Expenses: 47436000.00
HME.V balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 29514000.00
HME.V balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 76419000.00
HME.V balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 18106000.00
HME.V balance_sheet (annual, 2023-12-31) — Total Tax Payable: 7224000.00
HME.V income_statement (annual, 2023-12-31) — Total Unusual Items: -3960000.00
HME.V income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -3960000.00
HME.V balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
HME.V cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -625000.00
HME.V balance_sheet (annual, 2023-12-31) — Working Capital: 2910000.00
HME.V cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
HME.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 98439815.00
HME.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.09
HME.V balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 0.00
HME.V balance_sheet (quarterly, 2024-09-30) — Current Deferred Taxes Liabilities: 0.00
HME.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 100565277.00
HME.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.09
HME.V cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: -208000.00
HME.V balance_sheet (quarterly, 2024-09-30) — Hedging Assets Current: 0.00
HME.V income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
HME.V income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
HME.V income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: -9468000.00
HME.V cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: -208000.00
HME.V income_statement (annual, 2024-12-31) — +Operating Expense: 5306000.00
HME.V income_statement (annual, 2024-12-31) — +Total Revenue: 99935000.00
HME.V balance_sheet (annual, 2024-12-31) — Accounts Payable: 7657000.00
HME.V balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3616000.00
HME.V balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -94112000.00
HME.V balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 5170000.00
HME.V cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
HME.V cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
HME.V income_statement (annual, 2024-12-31) — Basic Average Shares: 98146591.00
HME.V income_statement (annual, 2024-12-31) — Basic EPS: 0.34
HME.V cash_flow (annual, 2024-12-31) — Beginning Cash Position: 7189000.00
HME.V cash_flow (annual, 2024-12-31) — Capital Expenditure: -11391000.00
HME.V cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -11391000.00
HME.V balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3795000.00
HME.V balance_sheet (annual, 2024-12-31) — Capital Stock: 60165000.00
HME.V balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 12550000.00
HME.V balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 12550000.00
HME.V cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -15703000.00
HME.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -20918000.00
HME.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -20269000.00
HME.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 46548000.00
HME.V cash_flow (annual, 2024-12-31) — Change In Working Capital: -7578000.00
HME.V cash_flow (annual, 2024-12-31) — Changes In Cash: 5361000.00
HME.V balance_sheet (annual, 2024-12-31) — Common Stock: 60165000.00
HME.V cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -15703000.00
HME.V balance_sheet (annual, 2024-12-31) — Common Stock Equity: 74379000.00
HME.V cash_flow (annual, 2024-12-31) — Common Stock Payments: -5539000.00
HME.V income_statement (annual, 2024-12-31) — Cost Of Revenue: 50074000.00
HME.V balance_sheet (annual, 2024-12-31) — Current Assets: 22676000.00
HME.V balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 826000.00
HME.V balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 826000.00
HME.V balance_sheet (annual, 2024-12-31) — Current Liabilities: 8773000.00
HME.V balance_sheet (annual, 2024-12-31) — Current Provisions: 158000.00
HME.V cash_flow (annual, 2024-12-31) — Deferred Income Tax: 10396000.00
HME.V cash_flow (annual, 2024-12-31) — Deferred Tax: 10396000.00
HME.V cash_flow (annual, 2024-12-31) — Depletion: 9294000.00
HME.V cash_flow (quarterly, 2024-12-31) — Depletion: 2306000.00
HME.V cash_flow (annual, 2024-12-31) — Depreciation: 952000.00
HME.V cash_flow (quarterly, 2024-12-31) — Depreciation: 273000.00
HME.V cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 10246000.00
HME.V cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 952000.00
HME.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 273000.00
HME.V income_statement (annual, 2024-12-31) — Diluted Average Shares: 100004909.00
HME.V income_statement (annual, 2024-12-31) — Diluted EPS: 0.33
HME.V income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 33103000.00
HME.V balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 9000.00
HME.V income_statement (annual, 2024-12-31) — EBIT: 44272000.00
HME.V income_statement (annual, 2024-12-31) — EBITDA: 54518000.00
HME.V cash_flow (annual, 2024-12-31) — End Cash Position: 12550000.00
HME.V cash_flow (annual, 2024-12-31) — Financing Cash Flow: -20918000.00
HME.V cash_flow (annual, 2024-12-31) — Free Cash Flow: 35157000.00
HME.V income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 75000.00
HME.V income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -664000.00
HME.V income_statement (annual, 2024-12-31) — General And Administrative Expense: 4943000.00
HME.V balance_sheet (annual, 2024-12-31) — Gross PPE: 182649000.00
HME.V income_statement (annual, 2024-12-31) — Gross Profit: 49861000.00
HME.V balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 0.00
HME.V balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 0.00
HME.V income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
HME.V income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
HME.V income_statement (annual, 2024-12-31) — Interest Expense: 746000.00
HME.V income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 746000.00
HME.V income_statement (annual, 2024-12-31) — Interest Income: 306000.00
HME.V income_statement (annual, 2024-12-31) — Interest Income Non Operating: 306000.00
HME.V cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 500000.00
HME.V balance_sheet (annual, 2024-12-31) — Invested Capital: 74379000.00
HME.V cash_flow (annual, 2024-12-31) — Investing Cash Flow: -20269000.00
HME.V balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2969000.00
HME.V balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2969000.00
HME.V cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -946000.00
HME.V balance_sheet (annual, 2024-12-31) — Long Term Provisions: 5840000.00
HME.V cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -5539000.00
HME.V cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
HME.V income_statement (annual, 2024-12-31) — Net Income: 33103000.00
HME.V income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 33103000.00
HME.V income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 33103000.00
HME.V income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 33103000.00
HME.V income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 33103000.00
HME.V cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 33103000.00
HME.V income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 33103000.00
HME.V income_statement (annual, 2024-12-31) — Net Interest Income: -440000.00
HME.V cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -946000.00
HME.V cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -946000.00
HME.V income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -440000.00
HME.V cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -8953000.00
HME.V balance_sheet (annual, 2024-12-31) — Net PPE: 88537000.00
HME.V cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 75000.00
HME.V balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 74379000.00
HME.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 19368000.00
HME.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 19368000.00
HME.V income_statement (annual, 2024-12-31) — Normalized EBITDA: 55107000.00
HME.V income_statement (annual, 2024-12-31) — Normalized Income: 33550954.49
HME.V cash_flow (annual, 2024-12-31) — Operating Cash Flow: 46548000.00
HME.V cash_flow (annual, 2024-12-31) — Operating Gains Losses: -75000.00
HME.V income_statement (annual, 2024-12-31) — Operating Income: 44555000.00
HME.V income_statement (annual, 2024-12-31) — Operating Revenue: 99935000.00
HME.V balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 97389735.00
HME.V balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 132000.00
HME.V balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 132000.00
HME.V income_statement (annual, 2024-12-31) — Other Gand A: 4918000.00
HME.V income_statement (annual, 2024-12-31) — Other Income Expense: -589000.00
HME.V cash_flow (annual, 2024-12-31) — Other Non Cash Items: 91000.00
HME.V balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 116000.00
HME.V income_statement (annual, 2024-12-31) — Other Operating Expenses: 363000.00
HME.V balance_sheet (annual, 2024-12-31) — Other Properties: 6848000.00
HME.V balance_sheet (annual, 2024-12-31) — Other Receivables: 5423000.00
HME.V balance_sheet (annual, 2024-12-31) — Payables: 7657000.00
HME.V balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 7657000.00
HME.V balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1078000.00
HME.V income_statement (annual, 2024-12-31) — Pretax Income: 43526000.00
HME.V cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1270000.00
HME.V balance_sheet (annual, 2024-12-31) — Properties: 175801000.00
HME.V balance_sheet (annual, 2024-12-31) — Receivables: 9048000.00
HME.V income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 50074000.00
HME.V income_statement (annual, 2024-12-31) — Reconciled Depreciation: 10246000.00
HME.V cash_flow (annual, 2024-12-31) — Repayment Of Debt: -946000.00
HME.V cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -5539000.00
HME.V balance_sheet (annual, 2024-12-31) — Retained Earnings: 9044000.00
HME.V income_statement (annual, 2024-12-31) — Salaries And Wages: 25000.00
HME.V cash_flow (annual, 2024-12-31) — Sale Of PPE: 75000.00
HME.V income_statement (annual, 2024-12-31) — Selling General And Administration: 4943000.00
HME.V balance_sheet (annual, 2024-12-31) — Share Issued: 97389735.00
HME.V income_statement (annual, 2024-12-31) — Special Income Charges: 75000.00
HME.V income_statement (quarterly, 2024-12-31) — Special Income Charges: 75000.00
HME.V cash_flow (annual, 2024-12-31) — Stock Based Compensation: 25000.00
HME.V balance_sheet (annual, 2024-12-31) — Stockholders Equity: 74379000.00
HME.V balance_sheet (annual, 2024-12-31) — Tangible Book Value: 74379000.00
HME.V income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -141045.51
HME.V income_statement (annual, 2024-12-31) — Tax Provision: 10423000.00
HME.V income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.24
HME.V balance_sheet (annual, 2024-12-31) — Total Assets: 111329000.00
HME.V balance_sheet (annual, 2024-12-31) — Total Capitalization: 74379000.00
HME.V balance_sheet (annual, 2024-12-31) — Total Debt: 3795000.00
HME.V balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 74379000.00
HME.V income_statement (annual, 2024-12-31) — Total Expenses: 55380000.00
HME.V balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 36950000.00
HME.V balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 88653000.00
HME.V balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 28177000.00
HME.V income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 35582000.00
HME.V balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
HME.V income_statement (annual, 2024-12-31) — Total Unusual Items: -589000.00
HME.V income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -589000.00
HME.V balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
HME.V balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
HME.V cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 340000.00
HME.V cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 72000.00
HME.V balance_sheet (annual, 2024-12-31) — Working Capital: 13903000.00
HME.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 1382000.00
HME.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 27339000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5568000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3803000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -97000000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 4762000.00
HME.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 97100296.00
HME.V income_statement (quarterly, 2025-03-31) — Basic EPS: 0.09
HME.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 12550000.00
HME.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1120000.00
HME.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -1120000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3573000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 59354000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 21389000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 21389000.00
HME.V cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2428000.00
HME.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -3877000.00
HME.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -3465000.00
HME.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 16181000.00
HME.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 3503000.00
HME.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: 8839000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 59354000.00
HME.V cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -2428000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 79674000.00
HME.V cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1301000.00
HME.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 13048000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 31130000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 875000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 875000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19056000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Current Provisions: 158000.00
HME.V cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 8000.00
HME.V cash_flow (quarterly, 2025-03-31) — Deferred Tax: 8000.00
HME.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2888000.00
HME.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 99004320.00
HME.V income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.09
HME.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 8942000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 11000.00
HME.V income_statement (quarterly, 2025-03-31) — EBIT: 12034000.00
HME.V income_statement (quarterly, 2025-03-31) — EBITDA: 14922000.00
HME.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 21389000.00
HME.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -3877000.00
HME.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 15061000.00
HME.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -986000.00
HME.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1297000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 183819000.00
HME.V income_statement (quarterly, 2025-03-31) — Gross Profit: 14291000.00
HME.V income_statement (quarterly, 2025-03-31) — Interest Expense: 177000.00
HME.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 177000.00
HME.V income_statement (quarterly, 2025-03-31) — Interest Income: 111000.00
HME.V income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 111000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 79674000.00
HME.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -3465000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2698000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2698000.00
HME.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -222000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 5864000.00
HME.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -1301000.00
HME.V cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -41000.00
HME.V income_statement (quarterly, 2025-03-31) — Net Income: 8942000.00
HME.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 8942000.00
HME.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 8942000.00
HME.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 8942000.00
HME.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 8942000.00
HME.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 8942000.00
HME.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 8942000.00
HME.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -66000.00
HME.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -222000.00
HME.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -222000.00
HME.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -66000.00
HME.V cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -2345000.00
HME.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 86819000.00